Symbotic Inc. (SYM) is listed on NASDAQ and operates in the Industrial - Machinery industry (Industrials sector).
Symbotic Inc., an automation technology company, provides robotics and technology to improve efficiency for retailers and wholesalers in the United States. It offers The Symbotic System, a full-service warehouse automation system that reduces costs, improves efficiency, and maximizes inventory. The company is based in Wilmington, Massachusetts.
| Rating | Analysts |
|---|---|
| Strong Buy | 0 |
| Buy | 11 |
| Hold | 3 |
| Sell | 4 |
| Strong Sell | 0 |
Symbotic Inc., headquartered in Wilmington, Massachusetts, operates within the industrial machinery sector, focusing on automation technology. The company specializes in providing robotics and technology solutions designed to enhance operational efficiency for retailers and wholesalers across the United States. Its primary offering, The Symbotic System, is a comprehensive warehouse automation system. This system aims to streamline operations by reducing costs, improving efficiency, and optimizing inventory management. Symbotic's solutions are tailored to meet the needs of businesses seeking to modernize their supply chain processes through advanced automation technologies. By integrating robotics into warehouse operations, the company supports clients in achieving more efficient and cost-effective logistics management.
Over the past three fiscal years, the company has demonstrated a robust growth trajectory, with revenue consistently increasing at a remarkable CAGR of 38.2%, from $1.18 billion in 2023 to $2.25 billion in 2025. Despite this top-line growth, profitability has been a challenge, as evidenced by the operating margin, which although improved by 13.8pp, remained negative at -5.1% in 2025. The net margin also saw a modest improvement of 1.3pp, ending at -0.8%. On the cash flow front, the company experienced significant volatility. Operating cash flow surged from $230.8 million in 2023 to $866.9 million in 2025, while free cash flow followed a similar pattern, increasing from $209.5 million to $787.9 million over the same period. This indicates a strong cash generation capability, despite the negative free cash flow in 2024. The company's net cash position improved significantly, with net debt decreasing from -$258.8 million to -$1.24 billion, suggesting a strengthening balance sheet. However, the 0.7% increase in share count over the period indicates some dilution, which may have moderated per-share gains. The company's working capital efficiency also improved, as reflected by a decrease in the cash conversion cycle from 22 days in 2024 to 12 days in 2025. Despite these improvements, the company's earnings quality remains a concern, with a negative cash conversion ratio of -61.4, indicating that earnings are not fully backed by cash.
Symbotic Inc. is set to release its second-quarter fiscal year 2026 financial results on May 6, 2026, after market close, with a webcast scheduled to discuss the outcomes. This announcement follows a recent analyst upgrade that saw Symbotic's stock price target increase to $73 by Northland Securities, causing shares to gap up and last trade at $59. The company has received an average "Hold" recommendation from analysts, with a 12-month price target of $64. In strategic developments, Symbotic has entered a significant partnership with Medline to pilot AI robotics technology in healthcare distribution centers starting in 2027. Institutional trading activity includes SG Americas Securities LLC selling 64,976 shares, while UBS Group AG and Allspring Global Investments Holdings LLC increased their positions in Symbotic, reflecting continued institutional interest. These developments highlight Symbotic's ongoing strategic initiatives and market positioning as it prepares for its upcoming financial disclosures.